GlassScriptPhysician profile
Michael Kopstein
NPI 1902251598
$10,209.73
in general payments reported to CMS, 2019-2025
30 companies · $4,501 in 2025
The $4,501 reported for 2025 was more than what 81% of Interventional Cardiology providers received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $244 · 2022: $1,451 · 2023: $1,497 · 2024: $2,517 · 2025: $4,501.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,605 · Travel and Lodging: $2,786 · Education: $124.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,605.48 |
| Travel and Lodging | $2,785.54 |
| Education | $123.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,092.24 | 2021-2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan, Onyx Frontier |
| Edwards Lifesciences Corporation | $2,090.02 | 2025 | Sapien 3 Ultra Resilia |
| Boston Scientific Corporation | $1,578.25 | 2021-2025 | General - Vascular Access, Avvigo Guidance System, Rotapro |
| Abiomed | $917.51 | 2022-2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $776.77 | 2021-2024 | Lifevest |
| Abbott Laboratories | $769.12 | 2022-2023 | Cardiomems, Mitraclip |
| E.R. Squibb & Sons, L.L.C. | $221.80 | 2021-2025 | Camzyos |
| Philips North America LLC | $218.98 | 2024 | (Bh4) Igt Devices Undivided |
| W. L. Gore & Associates, INC. | $135.60 | 2025 | Gore Cardioform Septal Occluder |
| Actelion Pharmaceuticals US, INC. | $132.58 | 2023-2025 | Opsumit, Uptravi |
| Janssen Pharmaceuticals, INC | $128.13 | 2023-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $127.65 | 2021-2024 | Wainua, Farxiga |
| Bayer Healthcare Pharmaceuticals INC. | $124.00 | 2023-2025 | |
| Lantheus Medical Imaging, INC. | $115.29 | 2023 | Definity |
| Amgen INC. | $107.13 | 2022-2023 | Repatha |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $88.10 | 2023-2025 | Soundstar, Carto 3 |
| Kiniksa Pharmaceuticals International, Plc | $72.56 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, LTD. | $68.02 | 2023 | Arcalyst |
| Chiesi USA, INC. | $51.22 | 2024 | Kengreal |
| Daiichi Sankyo INC. | $49.58 | 2023 | Injectafer |
| Alnylam Pharmaceuticals INC. | $48.04 | 2022-2025 | Amvuttra |
| Cardiva Medical, INC. | $45.74 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Pfizer INC. | $42.61 | 2022-2024 | |
| Kestra Medical Technology Services, INC. | $36.02 | 2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.33 | 2023 | Jardiance |
| Heartflow, INC. | $34.32 | 2025 | |
| United Therapeutics Corporation | $33.72 | 2023 | Tyvaso |
| Novartis Pharmaceuticals Corporation | $25.98 | 2025 | |
| Terumo Medical Corporation | $25.85 | 2024 | Glidewire, Heartrail |
| Atricure, INC. | $18.57 | 2025 | Atriclip Laa Exclusion System, Epi-Sense Guided Coagulation System With Visitrax, Synergy Ablation System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Kopstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.